Mymetics Corp. is a vaccine company, which focuses on the research and development of next generation vaccines for infectious and life disabling diseases. Its vaccine pipeline includes Influenza and RSV, HIV/AIDS, Malaria, Immunotheraphy, and COVID-19. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.